NSECertificate under SEBI (Depositories and Participants) Regulations, 201815 Jul 2026 · 15 Jul 2026, 06:50 pm

Certificate under SEBI (Depositories and Participants) Regulations, 2018

Global Health Limited · MEDANTA

✦ AI SummaryESG

Global Health Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018, regarding the Reconciliation of Share Capital Audit Report for the quarter ended June 30, 2026.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Global Health Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018.

Attachments (1)

📄

MEDANTA21_15072026184643_GHLRECOQUARTER30JUNE2026Signed.pdf

pdf

Download →
View document text
Limited July 15, 2026 Ref: - GHL/2026-27/EXCH/30 The General Manager The Manager Dept. of Corporate Services Listing Department BSE Limited, National Stock Exchange of India Limited P J Towers, Dalal Street, Exchange Plaza, C-1, Block G, Mumbai - 400 001 Bandra Kurla Complex, Bandra (E), Mumbai - 400 051 Scrip Code: 543654 Symbol: MEDANTA Sub: Certificate under Regulation 76 of SEBI (Depositories and Participants) Regulations, 2018 Dear Sir(s), Please find attached herewith the Certificate issued by M/s Mukesh Agarwal & Co., Practicing Company Secretary, dated July 14, 2026, regarding the Reconciliation of Share Capital Audit Report, for the quarter ended June 30, 2026. This is for your information and record. Thanking you, Yours Faithfully, For Global Health Limited Rahul Ranjan Company Secretary & Compliance Officer M. No. A17035 Encl: a/a Regd. Office: E-18, Defence Colony, New Delhi 110024, Ph No.011- 44114411 www.medanta.org, info@medanta.org, CIN: L85110DL2004PLC128319 MUKESH AGARWAL & CO. (COMPANY S~CRETARIES) 3029, Sant Nagar, Rani Bagh, Opp. M2K Pitampura, Delhi-110034 Tel. No. : 011-42458279, 47060535 Email: magarwalandco@gmail.com l Y• 01 • 2. o2b Ref. No. Dated .............................. . Reconciliation of Share Capital Audit According to our examination of all relevant books, registers, forms, documents and papers pertaining to the equity shares of GLOBAL HEALTH LIMITED (hereinafter referred to as the "Company") having its registered office at E-18, Medanta-Mediclinic, Defence colony, New Delhi 110024 as maintained by the Company and information provided to us by Kfin Technologies Limited, the Company's Registrar and Share Transfer Agent, having their office at Selenium Build_ing, Tower-B, Plot No 31 & 32, Financial District, Nanakramguda, Serilingampally, Rangareddi, Hyderabad, Telangana-500032, in respect of Reconciliation of Share Capital Audit as per Regulation 76 of Securities and Exchange Board of India (Depositories and Participants) Regulations, 20 I 8, we report as under:- 1. For Quarter ended June 30, 2026 2. ISIN INE474O01031 3. Face Value Rs. 2/- oer Equity Share 4. Name of the Company GLOBAL HEALTH LIMITED CIN L851 I0DL2004PLCl28319 5. Registered Office Address E-18, Medanta-Mediclinic. Defence Colony, New Delhi-I I 0024 6. Correspondence Address Medanta-The Medicity. Sector 38, Gurugram, Harvana-12200 I 7. Telephone No. & Fax No. Tel No. - 0124- 4834060 8. Email Address compliance@medanta.org Website httos://wwv1.medanta.orn: 9. Name of the Stock Exchange where the BSE Limited, Mumbai: and Companies Securities are listed National Stock Exchange of India Limited, Mumbai I 0. Issued Capital Number of Shares % of Total (Shares of Rs. 2/- each) Issued Capital 26,88,7 1,782 100% 11. Listed Capital 26,88,67,7 82 99.99% 12. Shares held in dematerialized form in l,81,11.621 6.73% CDSL 13. Shares held in dematerialized form in 25,07,56.159 93.26% NSDL 14. Physical 2 0.00% 15. Total No of Shares (12+13+14) 26,88,67,7 82 99.99% Page 1 Of4 16. Reasons for difference, if any, between The Company allotted 4,000 equity shares on ( 10 & 1 1) ,( 1 I & 15) June 24, 2026 under Part A of the GHL LTIP Reasons for difference, if any, between Scheme, 2024. The listing application and (10 & 15) corporate action approval were pending as at the close of the quarter enq_ed June 30, 2026. p..GARvz;_ C . 3851 '0 Page 2 0/4 17. Certifying the details of changes in share capital during the quarter under consideration as per table below:- Particulars No of Applied/ Listing on Whether Whether In- Shares Not Stock intimated intimated Principle applied Exchanges to CDSL to NSDL approval for Listing pending for SE (specify name) Allotment of 61,500 Applied Listed on Yes Yes No Equity shares on BSE April 22, 2026, Limited and pursuant to National options exercised Stock by employees, in Exchange pursuance of Part of India A of GHL Limited. Employee Long Term Share Based Incentive Plan, 2024. Allotment of 15,900 Applied Listed on Yes No1 No Equity shares on BSE May 23, 2026, Limited and pursuant to National options exercised Stock by employees, in Exchange pursuance of Part of India A of GHL Limited. Employee Long Term Share Based Incentive Plan, 2024. Allotment of 4,000 Not No3 No4 No No Equity shares on applied2 June 24, 2026, pursuant to options exercised by employees, -in pursuance of Part A of GHL Employee Long Term Share Based Incentive Plan, 2024. 1T he Company submitted the intimation to NSDL after the closure oft he quarter ended June 30, 2026. 2 The Company applied to NSEIBSEfor listing of4 ,000 equity shares after the closure oft he quarter ended June 30, 2026. 3 Listing approval from NSEIBSEfor the aforesaid 4,000 equity shares was received on July 09, 2026. 4 The Company intimated CDSL on July OJ, 2026, and the said shares were credited on July 07, 2026. Page 3 Of4 18. Register of Members is updated (Yes/No) Yes (if not update, upto which date) 19. Reference of previous quarter with Nil regards to excess dematerialized shares, if 20. Has the Company resolved the matter Not Applicable mentioned in point no 19 above in the current quarter? if not reason whv 21. Mentioned the total no. of requests, if any, NIL confirmed after 21 days and the total no. of requests pending beyond 21 days with the reason for delay. Total no ofDEMAT request No of request No of shares Reason for delay Confirmed after 21 days NIL NIL NIL Pending for more than 21 days NIL NIL NIL 22. Name, Telephone & Fax No of the Mr. Rahul Ranjan Compliance officer of the Company (Company Secretary & Compliance Officer) Tel No. -0124-4834060 23. Name, Address, Telephone & Fax No., CS. MUKESH KUMAR AGARWAL Regn No. of the Certifying CS C.P. No. 3851 Mis Mukesh Agarwal & Co; (Company Secretarie!>) 3029, Sant Nagar, Rani Bagh, New Delhi- 110034 Tel No:-011-42458279 24. Appointment of Common Registry for Mis KFIN TECHNOLOGIES LIMITED Share Registry work. If yes (name & Selenium Building, Tower-B, Plot No. 31 & address) 32, Financial District, Nanakramguda, Serilingampally, Rangareddi, Hyderabad, Telangana - 500032 Tel No. : 1800 309 400 I . E-mail Id : einward.ris(a)ktintech.com Website: www.kfintech.com 25. Any other details that the auditor may like N.A. to provide (e.g. BIFR Company, delisting from, company change its name.) For Mukesh Agarwal & Co (Compa ........- -- Date: 14.07.2026 Mukes I umar Place: Delhi Members/zip Number: C.P. No-3851 UDIN: F005991H000826030 Page 4 Of4